Research & Development in Biotechnology Industry
NAICS: 541711
For additional companies see the Scientific Research & Development Services Industry
Contents
Research & Development in Biotechnology Market Share: Largest Companies in the Research & Development in Biotechnology Industry
Company |
Headquarters | Revenue ($ MM) |
---|
MARSHALL UNIVERSITY | Huntington, WV | 100 |
SINCLAIR RESEARCH CENTER | Auxvasse, MO | 44 |
NANOSCALE COMBINATORIAL SYNTHESIS | Santa Clara, CA | 22 |
QUINTESSENTIAL BIOSCIENCES | Pleasant Grove, UT | 20 |
TEXCELL - NORTH AMERICA | Frederick, MD | 19 |
ETONBIO INC. DBA ETON BIOSCIENCE | San Diego, CA | 16 |
NAVITAS CLINICAL RESEARCH | Rockville, MD | 13 |
GENESIS BIOSCIENCES | Lawrenceville, GA | 13 |
ARISE BIOSCIENCE | Boca Raton, FL | 10 |
CHEMTRON BIOTECH | San Diego, CA | 9 |
REVEAL BIOSCIENCES | San Diego, CA | 8 |
TRIALWISE | Foster City, CA | 8 |
IREPERTOIRE | Huntsville, AL | 8 |
ESSENLIX | Monmouth Junction, NJ | 7 |
QUANTGENE | Santa Monica, CA | 6 |
BOSTON INSTITUTE OF BIOTECHNOLOGY | Waban, MA | 6 |
DNATRIX | Houston, TX | 6 |
WESTERN INSTITUTE FOR VETERANS RESEARCH | Salt Lake City, UT | 6 |
PHOENIX PHARMACEUTICALS | Burlingame, CA | 6 |
This is a list of the largest companies active in the Research & Development in Biotechnology industry. This differs from market share in the following example:
One business with revenues of $100 million generates 10% of its business from the Research & Development in Biotechnology industry. A second firm, with revenues of $20 million, generates all of its business from this industry. In our list, we show the businesses having revenues of $100 million and $20 million, respectively. However, the market share would compare the $10 million in industry-specific revenue to the $20 million: the second company has twice the market share even though it is "smaller" in size.
Growth: Fastest Growing Research & Development in Biotechnology Companies
A list of competitors in the Research & Development in Biotechnology industry that are rapidly expanding. Businesses may grow organically or through acquisition.
Typically, small or midsized companies are in "growth" mode and can expand more rapidly. However, large businesses may have the strategy and financial capabilities to scale rapidly.
Businesses that employ a "roll-up" strategy make multiple acquisitions of smaller businesses to form a single large corporation that controls a greater market share than its competitors and benefits from economies of scale.
View List
View Full List
Small Business Financing
Small businesses that have received financing may expand soon. Financing may be required for capital-intensive investments, such as real estate or equipment purchases. Research & Development in Biotechnology businesses may use the financing to cover startup expenses or the costs of hiring new employees.
Loans differ from equity investments in the level of risk that is expected: loans frequently have collateral either directly or implicitly through the business or the owners that ensure repayment. Equity investment has the possibility for much greater returns, but offers no guarantee the principle will be repaid. Convertible securities combine the two concepts, but is used by private-equity firms rather than main street startups.
View List
Venture Funding
These Research & Development in Biotechnology companies are actively raising capital from venture capital firms, private equity, or other investors. Businesses with venture funding generally
have higher growth prospects, either through bringing new concepts to market, using innovative business practices, or savvy management.
View List